IASLCREVIEW ARTICLE因-Considerations for Imaging of Malignant Pleural真Check for updatesMesothelioma:A Consensus Statement from theInternational Mesothelioma Interest GroupSharyn I.Katz,MD,MTR,a,*Christopher M.Straus,MD,Leonid Roshkovan,MD,aKevin G.Blyth,MD,Thomas Frauenfelder,MD,d Ritu R.Gill,MD,MPH,eFerry Lalezari,MD,Jeremy Erasmus,MD,Anna K.Nowak,M.B.B.S.,PhD,FRACP,hVictor H.Gerbaudo,PhD,MSHCA,i Roslyn J.Francis,M.B.B.S.,PhD,h.jSamuel G.Armato Ill,PhDbDepartment of Radiology,University of Pennsylvania Perelman School of Medicine,Philadelphia,PennsylvaniaPDepartment of Radiology,University of Chicago Pritzker School of Medicine,Chicago,IllinoisInstitute of Cancer Sciences,University of Glasgow,Glasgow,United KingdomdInstitute for Diagnostic and Interventional Radiology,University Hospital Zurich,Zurich,SwitzerlandDepartment of Radiology,Beth Israel Lahey Health,Harvard Medical School,Boston,MassachusettsDepartment of Radiology,Netherlands Cancer Institute,Amsterdam,The NetherlandssDepartment of Radiology,MD Anderson Cancer Center,Houston,TexasPMedical School,University of Western Australia,Perth,Australia'Department of Radiology,Brigham and Women's Hospital and Harvard Medical School,Boston,MassachusettsDepartment of Nuclear Medicine,Sir Charles Gairdner Hospital,Perth,AustraliaReceived 2 August 2022;revised 13 November 2022;accepted 17 November 2022Available online-20 December 2022ABSTRACTIntroductionMalignant pleural mesothelioma (MPM)is an aggressiveMalignant pleural mesothelioma (MPM)is a primaryprimary malignancy of the pleura that presents uniquemalignancy of the pleura that is typically aggressive andradiologic challenges with regard to accurate and repro-poorly responsive to therapy.MPM usually develops asducible assessment of disease extent at staging andthe result of asbestos exposure,although it can also befollow-up imaging.By optimizing and harmonizing tech-spontaneous or triggered by other exposures,such asnical approaches to imaging MPM,the best quality im-prior radiation therapy.Although considered a rareaging can be achieved for individual patient care,clinical disease,it is responsible for approximately 3000 casestrials,and imaging research.This consensus statementdiagnosed annually in the United States and an esti-represents agreement on harmonized,standard practicesmated 38,000 deaths every year worldwide;the exactfor routine multimodality imaging of MPM,includingnumber remains unknown owing to incomplete epide-radiography,computed tomography,18F-2-deoxy-D-miologic data.2-4Asbestos use and exposure remain aglucose positron emission tomography,and magneticconsiderable intemational public health issue,especiallyresonance imaging,by an international panel of experts inin the developing world.Treatment of patients withthe field of pleural imaging assembled by the Interna-tional Mesothelioma Interest Group.In addition,modality-specific technical considerations and future directions arediscussed.A bulleted summary of all technical re
